CEO Post: Pfizer Vet Leads 1 New Phase 3 Biotech Firm
A former Pfizer executive takes the coveted ceo post at a newly formed biotech company, ready to enter Phase 3 trials. Learn more about this strategic leadership move.
corporate leadership
Read More
Incoming CEO Pledges: 3 Ways to Get Kering’s Mojo Back
Kering’s new leadership makes incoming ceo pledges to revitalize the luxury group. Discover the key strategies planned to get the company’s ‘mojo back’.
Pfizer vet to lead 1 new phase 3-ready biotech as CEO
A long-time Pfizer vet has been appointed CEO of a newly formed biotech company. The firm is already poised to enter phase 3 trials for its lead candidate.